Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Will 2018 Be Johnson & Johnson's Best Year Yet?
Will 2018 Be Johnson & Johnson's Best Year Yet?
There are still several weeks left in the year, but Johnson & Johnson (NYSE: JNJ) appears to be on course to generate its second-highest stock performance over the last decade in 2017. A....
Will 2018 Be Johnson & Johnson's Best Year Yet?
Will 2018 Be Johnson & Johnson's Best Year Yet?
There are still several weeks left in the year, but Johnson & Johnson (NYSE: JNJ) appears to be on course to generate its second-highest stock performance over the last decade in 2017. A....
Here's How Acadia Pharmaceuticals Crushed It in 2017
Here's How Acadia Pharmaceuticals Crushed It in 2017
About 1 million patients in the U.S. suffer from Parkinson's disease. Unfortunately, nearly 40% of them will experience hallucinations and delusions in their daily life, which is a disease state....
Where Will Organovo Holdings, Inc. Be in 5 Years?
Where Will Organovo Holdings, Inc. Be in 5 Years?
This has been a year Organovo Holdings Inc. (NASDAQ: ONVO) investors would like to forget. Revenue growth has come to a halt, inciting the market to lop off roughly half of the company's market....
5 Top Biotech Stocks to Buy Now
5 Top Biotech Stocks to Buy Now
Over the last five years, biotech stocks have trounced the performance of the S&P 500. One major reason why is the number of new drugs launched by biotech companies. More diseases than ever....
The FDA Ushers In a New Era in Cancer Treatment
The FDA Ushers In a New Era in Cancer Treatment
On Thursday, Foundation Medicine (NASDAQ: FMI) won a green light for its comprehensive DNA test, FoundationOne CDx. The approval clears the way for healthcare providers to quickly determine what....
This Marijuana Stock Is Poised for a Breakout Year in 2018 -- Here's What You'll Want to Know About It
This Marijuana Stock Is Poised for a Breakout Year in 2018 -- Here's What You'll Want to Know About It
Admittedly, 2017 so far has kind of been a ho-hum year for former high-flying marijuana stock GW Pharmaceuticals (NASDAQ: GWPH). For the most part, investors have just been waiting for the next....
3 Biotech Stocks to Buy in December
3 Biotech Stocks to Buy in December
Black Friday is past. So is Cyber Monday. But it's not too late to buy one of the best Christmas gifts of all -- biotech stocks. Even if your family and friends might prefer other kinds of....
Better Buy: Pfizer Inc. vs. Johnson & Johnson
Better Buy: Pfizer Inc. vs. Johnson & Johnson
With only one month remaining in 2017, it's pretty clear which big pharma stock has been the better pick this year between Pfizer (NYSE: PFE) and Johnson & Johnson (NYSE: JNJ). J&J's share....
Better Buy: Pfizer Inc. vs. Johnson & Johnson
Better Buy: Pfizer Inc. vs. Johnson & Johnson
With only one month remaining in 2017, it's pretty clear which big pharma stock has been the better pick this year between Pfizer (NYSE: PFE) and Johnson & Johnson (NYSE: JNJ). J&J's share....
Why Intuitive Surgical Split Its Shares in 2017
Why Intuitive Surgical Split Its Shares in 2017
Investors know Intuitive Surgical (NASDAQ: ISRG) as a pioneer in the medical device industry, with its robotic surgical systems having revolutionized the way that doctors perform key procedures.....
Why Intuitive Surgical Split Its Shares in 2017
Why Intuitive Surgical Split Its Shares in 2017
Investors know Intuitive Surgical (NASDAQ: ISRG) as a pioneer in the medical device industry, with its robotic surgical systems having revolutionized the way that doctors perform key procedures.....
Why Intuitive Surgical Split Its Shares in 2017
Why Intuitive Surgical Split Its Shares in 2017
Investors know Intuitive Surgical (NASDAQ: ISRG) as a pioneer in the medical device industry, with its robotic surgical systems having revolutionized the way that doctors perform key procedures.....
Where Will Novavax, Inc. Be in 5 Years?
Where Will Novavax, Inc. Be in 5 Years?
Prediction is very difficult, especially if it's about the future.I've always liked that quote from Nobel prize-winning physicist Niels Bohr. And it's 100% correct, of course. But attempting to....
Why 2017 Was a Year to Remember for Exact Sciences Corporation
Why 2017 Was a Year to Remember for Exact Sciences Corporation
Any year that a stock goes up 40% would count as a memorable year. But what about a year where a stock soars nearly 340%? That's what has happened for Exact Sciences Corporation (NASDAQ: EXAS) in....
Here's Why Sangamo Therapeutics Rose as Much as 14.9% Thursday
Here's Why Sangamo Therapeutics Rose as Much as 14.9% Thursday
Shares of biopharma Sangamo Therapeutics (NASDAQ: SGMO) rose nearly 15% today after the company received favorable coverage in multiple media outlets. Biotech thought leaders STAT Plus and Genetic....
Gilead Sciences Stock Upgraded: This Is the Power of Free
Gilead Sciences Stock Upgraded: This Is the Power of Free
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
Gilead Sciences Stock Upgraded: This Is the Power of Free
Gilead Sciences Stock Upgraded: This Is the Power of Free
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
Gilead Sciences Stock Upgraded: This Is the Power of Free
Gilead Sciences Stock Upgraded: This Is the Power of Free
Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one....
Better Buy: Ziopharm Oncology Inc. vs. Celldex Therapeutics, Inc.
Better Buy: Ziopharm Oncology Inc. vs. Celldex Therapeutics, Inc.
The American Cancer Society expects 600,920 Americans to die from cancer this year, but Ziopharm Oncology Inc. (NASDAQ: ZIOP) and Celldex Therapeutics, Inc. (NASDAQ: CLDX) aim to lower that....
Will 2018 Be Intuitive Surgical, Inc.'s Best Year Yet?
Will 2018 Be Intuitive Surgical, Inc.'s Best Year Yet?
Intuitive Surgical, Inc. (NASDAQ: ISRG) shareholders have plenty of reasons to enjoy a happy holiday season. The stock is at an all-time high. Intuitive Surgical is on track to generate $3 billion....
Will 2018 Be Intuitive Surgical, Inc.'s Best Year Yet?
Will 2018 Be Intuitive Surgical, Inc.'s Best Year Yet?
Intuitive Surgical, Inc. (NASDAQ: ISRG) shareholders have plenty of reasons to enjoy a happy holiday season. The stock is at an all-time high. Intuitive Surgical is on track to generate $3 billion....
Will 2018 Be Intuitive Surgical, Inc.'s Best Year Yet?
Will 2018 Be Intuitive Surgical, Inc.'s Best Year Yet?
Intuitive Surgical, Inc. (NASDAQ: ISRG) shareholders have plenty of reasons to enjoy a happy holiday season. The stock is at an all-time high. Intuitive Surgical is on track to generate $3 billion....
Will Johnson & Johnson Do a Stock Split in 2018?
Will Johnson & Johnson Do a Stock Split in 2018?
Healthcare has been an exciting industry lately, and Johnson & Johnson (NYSE: JNJ) casts a wide net over the sector. The company not only sells well-known consumer brands like Tylenol and....
Will Johnson & Johnson Do a Stock Split in 2018?
Will Johnson & Johnson Do a Stock Split in 2018?
Healthcare has been an exciting industry lately, and Johnson & Johnson (NYSE: JNJ) casts a wide net over the sector. The company not only sells well-known consumer brands like Tylenol and....